Lactose (India) Ltd | 137 Cr. | 96.9 | 247/84.3 | 26.5 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 5.02 Cr. | 2.63 | 4.33/2.50 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 40.4 Cr. | 54.4 | 94.9/44.5 | | 8.73 | 0.00 % | 41.5 % | 14.4 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 39.0 Cr. | 26.6 | 29.1/13.1 | 38.3 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 73.0 Cr. | 97.0 | 155/79.0 | 16.7 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 42,241 Cr. | 1,498 | 1,831/1,037 | 32.0 | 314 | 0.17 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 301 Cr. | 13.2 | 29.0/11.2 | 18.6 | 8.21 | 0.00 % | 12.5 % | 9.03 % | 1.00 |
Ganga Pharmaceuticals Ltd | 6.44 Cr. | 13.3 | 27.1/9.25 | 80.5 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 336 Cr. | 712 | 956/635 | 16.2 | 277 | 0.10 % | 22.3 % | 17.1 % | 10.0 |
Fervent Synergies Ltd | 87.4 Cr. | 20.0 | 32.0/14.6 | 29.6 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 936 Cr. | 318 | 449/145 | 12.3 | 123 | 0.39 % | 21.7 % | 23.4 % | 5.00 |
Fabino Enterprises Ltd | 5.20 Cr. | 24.8 | 36.5/22.8 | 40.0 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 10.1 Cr. | 4.04 | 12.3/2.11 | 112 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 421 Cr. | 434 | 477/112 | | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,336 Cr. | 1,226 | 1,584/991 | 56.3 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 173 Cr. | 1.86 | 2.72/1.03 | 23.0 | 2.24 | 0.00 % | 4.21 % | 5.69 % | 2.00 |
Dipna Pharmachem Ltd | 53.5 Cr. | 22.2 | 26.3/6.40 | 64.4 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 11.6 Cr. | 11.4 | 24.6/10.0 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 226 Cr. | 633 | 999/465 | 9.13 | 563 | 0.32 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 31.5 Cr. | 31.5 | 45.0/26.1 | 105 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 29.4 Cr. | 64.4 | 88.7/36.0 | 58.9 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 9.74 Cr. | 3.90 | 26.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 20.9 Cr. | 139 | 154/55.1 | 61.4 | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 10.2 Cr. | 18.7 | 28.9/6.08 | 341 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 42.2 Cr. | 56.0 | 114/46.2 | 49.1 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 5.16 Cr. | 17.2 | 27.8/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 15,939 Cr. | 918 | 969/347 | 52.2 | 65.3 | 0.11 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 115 Cr. | 26.6 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 9.39 Cr. | 18.5 | 46.0/17.4 | 16.2 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 144 Cr. | 251 | 418/241 | 15.6 | 119 | 1.80 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 24.5 Cr. | 41.6 | 62.6/14.8 | 61.2 | 43.2 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 66,627 Cr. | 1,137 | 1,593/994 | 19.1 | 557 | 0.40 % | 14.3 % | 11.2 % | 1.00 |
Auro Laboratories Ltd | 161 Cr. | 258 | 298/156 | 87.3 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 1,091 Cr. | 217 | 250/148 | 23.0 | 65.1 | 1.15 % | 19.5 % | 15.3 % | 5.00 |
ANG Lifesciences India Ltd | 37.9 Cr. | 29.0 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Ami Organics Ltd | 9,630 Cr. | 1,176 | 1,322/504 | 60.7 | 160 | 0.13 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 5.68 Cr. | 0.86 | 1.45/0.55 | 568 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 284 Cr. | 37.1 | 77.7/34.1 | 28.4 | 18.3 | 0.00 % | 8.60 % | 7.23 % | 10.0 |
Adline Chem Lab Ltd | 8.55 Cr. | 14.6 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 78.4 Cr. | 3.33 | 6.25/2.82 | 143 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 65,040 Cr. | 30,605 | 31,900/25,260 | 46.0 | 1,992 | 1.34 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 8,074 Cr. | 890 | 926/496 | 29.6 | 220 | 0.34 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 146 Cr. | 51.8 | 75.8/31.3 | 36.3 | 48.8 | 0.00 % | 6.00 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 2,863 Cr. | 973 | 1,078/440 | | 78.1 | 0.10 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 23,833 Cr. | 1,466 | 1,680/489 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 975 Cr. | 298 | 330/131 | 31.9 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 612 Cr. | 459 | 477/270 | 15.7 | 420 | 0.00 % | 11.4 % | 7.45 % | 10.0 |
Unichem Laboratories Ltd | 4,182 Cr. | 595 | 950/501 | 30.4 | 348 | 0.00 % | 6.36 % | 5.71 % | 2.00 |
TTK Healthcare Ltd | 1,707 Cr. | 1,219 | 1,923/991 | 24.0 | 754 | 0.82 % | 9.25 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,05,879 Cr. | 3,128 | 3,591/2,570 | 54.9 | 224 | 1.02 % | 27.2 % | 26.7 % | 5.00 |
Themis Medicare Ltd | 1,232 Cr. | 134 | 317/115 | 41.3 | 43.7 | 0.37 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 2,049 Cr. | 21.8 | 27.9/11.0 | 41.9 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,473 Cr. | 1,079 | 1,360/597 | 98.5 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 5,371 Cr. | 246 | 257/83.0 | | 5.04 | 0.00 % | 84.4 % | 84.6 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,01,625 Cr. | 1,675 | 1,960/1,377 | 35.0 | 301 | 0.81 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,106 Cr. | 478 | 886/367 | 3,900 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,308 Cr. | 260 | 398/175 | 33.8 | 75.9 | 0.15 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 391 Cr. | 1,293 | 1,750/681 | 20.9 | 650 | 0.12 % | 11.8 % | 10.0 % | 10.0 |
Shilpa Medicare Ltd | 8,673 Cr. | 886 | 960/418 | 96.9 | 243 | 0.00 % | 7.94 % | 4.28 % | 1.00 |
Sequent Scientific Ltd | 4,951 Cr. | 198 | 241/91.8 | 224 | 28.1 | 0.00 % | 8.97 % | 3.25 % | 2.00 |
Sanofi India Ltd | 14,105 Cr. | 6,141 | 7,600/4,146 | 37.1 | 374 | 1.91 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,588 Cr. | 2,172 | 2,977/1,381 | 30.3 | 321 | 0.74 % | 33.3 % | 26.1 % | 8.00 |
Procter & Gamble Health Ltd | 9,510 Cr. | 5,757 | 5,944/4,641 | 36.6 | 323 | 1.39 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 214 Cr. | 60.7 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 25,722 Cr. | 5,624 | 6,453/3,701 | 40.2 | 922 | 0.62 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 126 Cr. | 102 | 348/81.0 | 9.43 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 3,086 Cr. | 504 | 582/112 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,337 Cr. | 660 | 1,998/604 | 33.5 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 14,979 Cr. | 11,674 | 18,100/5,540 | 73.9 | 1,188 | 0.12 % | 18.2 % | 14.4 % | 10.0 |
Nectar Lifescience Ltd | 561 Cr. | 25.0 | 56.5/20.0 | 33.0 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 15,727 Cr. | 878 | 1,639/660 | 8.35 | 425 | 1.08 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 3,555 Cr. | 64.9 | 101/41.7 | 30.1 | 21.1 | 0.00 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 11,557 Cr. | 255 | 359/130 | 30.4 | 54.4 | 0.24 % | 20.1 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 128 Cr. | 80.4 | 145/70.1 | 18.5 | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 427 Cr. | 119 | 177/90.2 | 53.9 | 29.0 | 0.00 % | 9.93 % | 9.24 % | 10.0 |
Lupin Ltd | 89,515 Cr. | 1,961 | 2,403/1,493 | 27.3 | 377 | 0.41 % | 21.5 % | 20.8 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,095 Cr. | 547 | 980/498 | 13.3 | 335 | 0.33 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 32,981 Cr. | 611 | 661/385 | 86.7 | 84.6 | 0.20 % | 10.4 % | 8.67 % | 2.00 |
Kwality Pharmaceuticals Ltd | 948 Cr. | 914 | 1,070/481 | 23.8 | 256 | 0.00 % | 18.3 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 163 Cr. | 75.5 | 129/60.3 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 908 Cr. | 188 | 370/155 | 23.6 | 107 | 1.60 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 683 Cr. | 430 | 500/271 | 27.4 | 126 | 0.00 % | 17.3 % | 13.2 % | 10.0 |
Jubilant Pharmova Ltd | 18,656 Cr. | 1,170 | 1,310/617 | 33.6 | 393 | 0.43 % | 9.54 % | 9.50 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,158 Cr. | 1,684 | 2,030/1,303 | 39.7 | 221 | 0.73 % | 26.6 % | 20.8 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,574 Cr. | 237 | 328/109 | 39.6 | 36.1 | 0.84 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 35,941 Cr. | 1,416 | 1,758/1,052 | 41.5 | 274 | 0.28 % | 15.0 % | 13.1 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,632 Cr. | 89.7 | 108/57.5 | 26.1 | 57.5 | 1.11 % | 8.85 % | 6.12 % | 2.00 |
Ind-Swift Ltd | 89.3 Cr. | 16.5 | 34.7/12.0 | 1.39 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 501 Cr. | 82.1 | 186/67.2 | 6.05 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,392 Cr. | 259 | 388/190 | | 111 | 0.58 % | 0.48 % | 7.00 % | 2.00 |
Hikal Ltd | 4,627 Cr. | 376 | 465/267 | 51.0 | 102 | 0.32 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,540 Cr. | 1,809 | 3,379/1,243 | 56.0 | 369 | 0.33 % | 9.62 % | 9.07 % | 10.0 |
Gufic BioSciences Ltd | 3,673 Cr. | 366 | 504/278 | 52.5 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 12,834 Cr. | 529 | 725/401 | 26.8 | 153 | 0.28 % | 15.1 % | 13.8 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 42,260 Cr. | 1,498 | 1,831/1,037 | 32.1 | 314 | 0.17 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 55,414 Cr. | 3,271 | 3,398/1,921 | 60.0 | 115 | 1.28 % | 66.9 % | 49.6 % | 10.0 |
Gland Pharma Ltd | 26,555 Cr. | 1,612 | 2,221/1,200 | 24.4 | 592 | 1.24 % | 15.9 % | 11.6 % | 1.00 |
FDC Ltd | 7,141 Cr. | 439 | 659/359 | 26.8 | 140 | 1.14 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 21,328 Cr. | 1,566 | 1,664/816 | 60.6 | 210 | 0.47 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,04,115 Cr. | 1,248 | 1,421/1,020 | 18.4 | 402 | 0.64 % | 23.1 % | 18.3 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,232 Cr. | 270 | 308/133 | | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,18,739 Cr. | 1,470 | 1,702/1,310 | 22.5 | 386 | 0.88 % | 23.3 % | 18.2 % | 2.00 |
Caplin Point Laboratories Ltd | 16,417 Cr. | 2,160 | 2,641/1,221 | 30.6 | 375 | 0.23 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 438 Cr. | 149 | 203/72.5 | | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,409 Cr. | 134 | 186/92.2 | 16.7 | 99.7 | 0.37 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 78.9 Cr. | 48.5 | 92.0/40.4 | 141 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 40,100 Cr. | 334 | 405/270 | 41.7 | 180 | 0.15 % | 6.13 % | 4.64 % | 5.00 |
Beta Drugs Ltd | 1,904 Cr. | 1,887 | 2,215/1,048 | 41.6 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 155 Cr. | 97.3 | 158/76.3 | 21.4 | 48.6 | 1.23 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 177 Cr. | 75.0 | 96.0/67.8 | 28.2 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 23,341 Cr. | 9,336 | 9,488/5,416 | 133 | 308 | 0.26 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,096 Cr. | 725 | 863/544 | 41.2 | 113 | 0.63 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 209 Cr. | 99.5 | 145/69.9 | 10.6 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 60,936 Cr. | 5,096 | 6,440/4,407 | 28.1 | 1,002 | 0.78 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 19,578 Cr. | 996 | 1,304/725 | 34.3 | 264 | 1.10 % | 13.1 % | 11.4 % | 2.00 |
Albert David Ltd | 460 Cr. | 806 | 1,754/763 | 26.8 | 688 | 1.43 % | 6.48 % | 4.44 % | 10.0 |
Ajanta Pharma Ltd | 31,903 Cr. | 2,554 | 3,486/2,022 | 34.7 | 290 | 1.41 % | 33.3 % | 25.6 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,412 Cr. | 305 | 571/258 | 26.0 | 127 | 1.31 % | 13.0 % | 9.55 % | 2.00 |
Aarti Drugs Limited | 4,311 Cr. | 469 | 635/312 | 27.4 | 136 | 0.21 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,382.36 Cr | 1,142.76 | | 88.40 | 194.54 | 0.31% | 16.74% | 15.24% | 6.19 |